Weekly Insights & Analysis
Healthcare Private Placement and M&A Transactions Review Week Ending April 16, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions TORL BioTherapeutics: The company raised $158 million of Series B venture funding in a deal led by Goldman Sachs Asset Management April 13, 2023. Moore Strategic Ventures and 7 other investors...
Consumer Private Placement and M&A Transactions Review Week Ending April 16, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Ynsect: The company raised $175 million of venture funding from undisclosed investors on April 16, 2023. The company is an operator of insect vertical farms intended to produce premium organic...
Technology Private Placement and M&A Transactions Review Week Ending April 9, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Covariant: The company raised $155 million of Series C venture funding in a deal led by Index Ventures and Radical Ventures on April 4, 2023. Gates Frontier, Northgate Capital, Amplify...
Healthcare Private Placement and M&A Transactions Review Week Ending April 9, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Mercy BioAnalytics: The company raised $41 million of Series A venture funding in a deal led by Novalis LifeSciences on April 3, 2023, putting the company's pre-money valuation at $81 million....
Consumer Private Placement and M&A Transactions Review Week Ending April 9, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Vytelle: The company raised $20 million of Series B venture funding in a deal led by Forage Capital Partners on April 3, 2023. Fulcrum Global Capital, Serra Ventures, KCRise Fund, Mountain...
A weekly digest of strategy and finance perspectives in charts, together with a review of M&A and private placement transactions by industry sector.